# Added Value of Contrast-enhanced Ultrasonography for Percutaneous Radiofrequency Ablation

> **NCT05445973** · NA · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 248 (actual)

## Conditions studied

- Radiofrequency Ablation
- Ultrasonography
- Liver Tumors

## Interventions

- **PROCEDURE:** Percutaneous Radiofrequency Ablation

## Key facts

- **NCT ID:** NCT05445973
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-01
- **Primary completion:** 2021-04-30
- **Final completion:** 2022-01-30
- **Target enrollment:** 248 (ACTUAL)
- **Last updated:** 2022-07-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05445973

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05445973, "Added Value of Contrast-enhanced Ultrasonography for Percutaneous Radiofrequency Ablation". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05445973. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*